SELENOS and von Hippel-Lindau disease: This interplay between Von Hippel–Lindau syndrome, hypoxia, and low expression of selenoproteins may close a self-amplifying cycle of progressive inflammation and damage, and may positively be affected by anti-inflammatory therapy in combination with adjuvant supplemental Se.